Table 3.
Virological suppression odds ratio (95% confidence interval) |
Virological suppression adjusted odds ratio (95% confidence interval) |
|||
---|---|---|---|---|
Characteristic | Bivariate analysis | p-Value | Multivariate | p-Value |
Category | ||||
MI & DU | 0.67 (0.57-0.79) | <0.01 | 0.66 (0.58-0.75) | <0.01 |
DU | 0.78 (0.66-0.92) | <0.01 | 0.77 (0.67-0.88) | <0.01 |
MI | 0.84(0.76-0.93) | <0.01 | 0.93 (0.82-1.05) | 0.24 |
Neither MI nor DU | 1.00 (referent) | 1.00 (referent) | ||
Age (years) | ||||
≥45 | 1.89 (1.67-2.14) | <0.01 | 2.07 (1.87-2.37) | <0.01 |
>35 & <45 | 1.41 (1.25-1.60) | <0.01 | 1.49 (1.39-1.70) | <0.02 |
≤35 | 1.00 (referent) | 1.00 (referent) | ||
Gender | ||||
Male | 1.12 (1.00-1.23) | 0.06 | 0.99 (0.89-1.12) | 0.98 |
Female | 1.00 (referent) | 1.00 (referent) | ||
Race/Ethnicity | ||||
Black/African American | 0.74 (0.66-0.83) | <0.01 | 0.81 (0.72-0.91) | <0.01 |
Hispanic | 0.89 (0.79-1.01) | 0.08 | 1.03 (0.90-1.18) | 0.50 |
Other | 1.42 (1.06-1.90) | 0.02 | 1.46 (1.08-1.98) | 0.01 |
White/Caucasian | 1.00 (referent) | 1.00 (referent) | ||
CD4 count (cells/mm3) | ||||
>200 | 1.87 (1.70-2.05) | <0.01 | 1.89 (1.71-2.07) | <0.01 |
≤200 | 1.00 (referent) | 1.00 (referent) | ||
Outpatient medical visits during calendar year 2004 | ||||
≥7 | 0.51 (0.45-0.57) | <0.01 | 0.52 (0.46-0.59) | <0.01 |
4-6 | 0.88 (0.78-0.98) | 0.02 | 0.87 (0.78-0.98) | 0.02 |
<4 | 1.00 (referent) | 1.00 (referent) | ||
Years in clinical care | 1.03 (1.02-1.05) | 1.03 (1.02-1.05) | <0.01 |
Analysis adjusted for site.